I-Sofosbuvir Intermediate CAS 21382-82-1 Purity ≥98.0% (HPLC)
I-Sofosbuvir Yezohwebo kanye Nezixhumanisi Ezihlobene:
I-Sofosbuvir CAS: 1190307-88-0
I-N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
I-Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Igama | i-triphenyl (1- [ethoxycarbonyl] ethylidene) phosphorane |
Omqondofana | 2-(triphenyl-phosphanylidene) -propionic acid ethyl ester |
Inombolo ye-CAS | 21382-82-1 |
Inombolo yeCAT | I-RF-PI179 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C23H23O2P |
Isisindo samangqamuzana | 362.41 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ephuzi |
Ukuhlanzeka / Indlela Yokuhlaziya | ≥98.0% (HPLC) |
Ukulahlekelwa Ekumisweni | ≤1.0% (60℃, 2h) |
Isamba se-PH3P+PH3PO | ≤2.0% (HPLC) |
Into Ehlobene Engashiwongo | ≤0.5% (HPLC) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Sofosbuvir (CAS: 1190307-88-0) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
Umkhiqizi onokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
I-Commercial Supply Sofosbuvir (CAS: 1190307-88-0) kanye Nezixhumanisi Ezihlobene:
I-Sofosbuvir CAS: 1190307-88-0
I-N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
I-L-Alanine Isopropyl Ester Hydrochloride CAS: 62062-65-1
I-Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
I-Sofosbuvir isidakamizwa esisetshenziselwa ukwelapha isifo sokusha kwesibindi kohlobo C. Kunconywa ukuthi sisetshenziswe ngokuhambisana nezinye izidakamizwa (njenge-velpatasvir) ekwelapheni komugqa wokuqala we-HCV genotypes 1, 2, 3, 4, 5, kanye no-6. Iqala ukusebenza ngokusebenza njenge-nucleotide analog inhibitor, ekwazi ukuvimbela ngokukhethekile i-HCV NS5B (i-non-structural protein 5B) i-RNA polymerase encike ku-RNA.